RecruitingPhase 2NCT06226883
A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Houma, LA · +24 more sites
2 recruiting crohn's disease studies with a site in Houma, LA.
Sponsor: Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)
Houma, LA · +24 more sites
Sponsor: Sanofi
Baton Rouge, LA · Houma, LA · Mandeville, LA · +122 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.